baber/WOPTO huggingface dataset:
Patent AU-2011261756-A1 (AU)
Title: User-specific noise suppression for voice quality improvements
Inventor: LINDAHL ARAM
IPC: G10L21/02
Filed: 2011-05-18
Abstract: Systems, methods, and devices for user-specific noise suppression are provided. For example, when a voice-related feature of an electronic device (10) is in use, the electronic device (10) may receive an audio signal that includes a user voice. Since noise, such as ambient sounds (60), also may be received by the electronic device (10) at this time, the electronic device (10) may suppress such noise in the audio signal. In particular, the electronic device (10) may suppress the noise in the audio signal while substantially preserving the user voice via user-specific noise suppression parameters. These user-specific noise suppression parameters may be based at least in part on a user noise suppression preference or a user voice profile, or a combination thereof.
Patent AU-2011268127-A1 (AU)
Title: PLA2G16 as a target for antiviral compounds
Inventor: BRUMMELKAMP THIJN R
IPC: G01N33/68
Filed: 2011-06-17
Abstract: In some aspects, the invention provides compositions and methods for inhibiting viral infection. In some aspects, the invention provides compositions and methods useful for identifying antiviral compounds.
Patent AU-2011292811-A1 (AU)
Title: Method of treating municipal wastewater and producing biomass with biopolymer production potential
Inventor: BENGTSSON SIMON OLOF HARALD
IPC: C02F3/12
Filed: 2011-08-17
Abstract: A method of biologically treating wastewater and removing contaminants from the wastewater is disclosed. In the course of treating the wastewater, biomass is produced. In addition to removing contaminants from the wastewater, the process or method of the present invention entails enhancing the PHA accumulation potential of the biomass. Disclosed are a number of processes that are employed in a biological wastewater treatment system for enhancing PHA accumulation potential. For example, enhanced PHA accumulation potential is realized by exposing the biomass to feast and famine conditions and, after exposing the biomass to famine conditions, stimulating the biomass into a period of feast by exposing the biomass to feast conditions for a selected period of time by applying an average peak stimulating RBCOD feeding rate of greater than 5 mg-COD\L\MIN in combination with an average peak specific RBCOD feeding rate greater than 0.5 mg-COD\g-VSS\MIN. In another example, the PHA accumulation potential of the biomass is enhanced by subjecting the biomass to feast conditions that cause the biomass to reach a peak respiration rate that is at least 40% of the extant maximum respiration rate of the biomass. Other processes are discussed that can contribute to enhancing PHA accumulation potential of biomass.
Patent AU-2011302404-A1 (AU)
Title: Removal of non-volatiles from ammonia - based C02 -absorbent solution
Inventor: NAUMOVITZ JOSEPH P
IPC: B01D53/96
Filed: 2011-09-07
Abstract: A system is arranged to remove carbon dioxide (CO2) from a gas stream by bringing the gas stream into contact with a circulating ammoniated solution stream such that CO2 is removed from the gas stream by the ammoniated solution stream. A method of removing non-volatile compounds from the circulating ammoniated solution stream includes: introducing a portion of the circulating ammoniated solution stream into a gas-liquid separating device; and separating the introduced ammoniated solution into an ammonia rich gas phase and a liquid phase comprising the non-volatile compounds; and reintroducing the ammonia rich gas phase into the circulating ammoniated solution stream.
Patent AU-2011373249-A1 (AU)
Title: System of containers having interchangeable components and method of manufacturing the same
Inventor: CRAWFORD JOHN C
IPC: B65D47/08
Filed: 2011-07-21
Abstract: The present invention, in one aspect, is directed to a system of containers having interchangeable container bodies (110, 210) and closures (150, 250). The system comprises at least two container bodies having different three-dimensional geometries and at least two closures having different three-dimensional geometries. Each of the closures comprises a fitment that can be coupled to a coupling structure (130, 230) of each of the container bodies, thereby affording each of the closures the ability to be coupled to each of the container bodies, and vice versa. As a result, the formation of only two different closures and two different container bodies results in the ability to create four different containers by simply rearranging the closure/container body combination.
Patent AU-2012200538-A1 (AU)
Title: Tumor necrosis factor inhibitors
Inventor: GREENE MARK I
IPC: A61K31/222
Filed: 2012-01-31
Abstract: The present invention is directed to compounds that are allosteric inhibitors of tumor necrosis factor receptor I, compositions comprising such compounds, and methods of using such compounds and compositions thereof in the treatment of TNF-a mediated conditions.
Patent AU-2012202230-A1 (AU)
Title: Rigging for vehicles
Inventor: WINNINGTON-INGRAM CHRISTOPHER
IPC: B63H9/10
Filed: 2012-04-17
Abstract: A slider shoe fitting for a gnav assembly (8) for exerting a downward force on a boom (5). The slider shoe fitting comprises a boom slider (10) for 5 sliding along an upper portion of a surface of a boom, and a strut portion for forming at least part of a strut of the gnav assembly (8). The boom slider (10) comprises a body portion (11) and a plurality of upstanding portions (15). The body portion (11) and upstanding portions (15) are of a single piece of material. The strut portion is pivotally mounted to the 10 plurality of upstanding portions (15). \ / 6
Patent AU-2012203622-A1 (AU)
Title: Foldable leg rest
Inventor: Yin qing-kun
IPC: B60N2/90
Filed: 2012-06-21
Abstract: A foldable leg rest includes a base (10), a first folding assembly (20) and a second folding assembly (30). The base (10) has a mounting board (I1) and a first stage drive mechanism mounted on the mounting board (11). The 5 first folding assembly (20) is pivotally connected to the base (10) and has a first frame (21) and a second stage drive mechanism mounted in the first frame (21). The second folding assembly (30) is pivotally connected to the first folding assembly (20). In use, the first stage drive mechanism is operated to drive the first folding assembly (20) to pivot relative to the base (10) and the second 10 stage drive mechanism is operated to drive the second folding assembly (30) to pivot relative to the first folding assembly (20). Therefore, the legs of a sitter can be stretched and placed on the folding assemblies (20,30). C') T- C- <? o < 00
Patent AU-2012221736-A1 (AU)
Title: Preloadable support
Inventor: KILLASSY NATALIE
IPC: E21D15/48
Filed: 2012-02-24
Abstract: The invention relates to a load support (1) comprising a container (2) manufactured from a flexible material, having at least one side wall (4), a top panel (3), a bottom panel (5), and a filler aperture (13). The side wall (4) has a predetermined height selected to be greater than the installation height of the support (1), operatively to allow for vertical expansion of the top of the container (2) into contact with the roof upon filling of the container (2) with a filler material.
Patent AU-2012238225-A1 (AU)
Title: Method of use of orally administered probiotic bifidobacteria for human beauty benefits
Inventor: O'MAHONY LIAM DIAMUID
IPC: A23L1/30
Filed: 2012-10-05
Abstract: A method of regulating the condition of keratinous tissue in a human subject comprising orally administering to the human subject a composition comprising a probiotic Bifidobacteria selected from the group consisting of Bifidobacteria having accession numbers NCIMB 41050, NCIMB 41051, NCIMB 41052, NCIMB 41053, NCIMB 41099, NCIMB 41100, NCIMB 41003, mutants thereof, and mixtures thereof. OV954957.0510.12
Patent AU-2012244859-A1 (AU)
Title: Triazolopyridines
Inventor: SCHULZE VOLKER
IPC: A61P35/00
Filed: 2012-04-16
Abstract: The present invention relates to triazolopyridine compounds of general formula (I) : in which R
Patent AU-2012246686-A1 (AU)
Title: Tow for aircraft
Inventor: PUGH CHARLES R
IPC: B60P3/11
Filed: 2012-03-23
Abstract: A tow vehicle for aircraft comprises a nose gear support assembly that can be raised and lowered relative to the vehicle about a first pivot axis. The support assembly can comprise a base portion and nose gear support portion pivotal about an upright axis relative to the base portion. Bearings can be positioned inwardly of the periphery of the support portion to support the support portion on the base portion. The bearings can be positioned partially in pockets provided in the base portion and in recesses in the support portion. A torque sensor can be coupled to the base portion and support portion and be operable to provide an output signal indicative of the torque between these components. An indicator, such as an alarm, can indicate when the torque exceeds first and second thresholds and can be operational to remain on if a second higher threshold is exceeded until, for example, a supervisor or other authorized individual turns off the indicator.
Patent AU-2012259346-A1 (AU)
Title: Primary flight display pitch- and power-based unreliable airspeed symbology
Inventor: THOREEN ADAM MARSHALL
IPC: G01C23/00
Filed: 2012-04-17
Abstract: A system for displaying pitch- and power-based guidance commands and flight path information for a variety of display modes (climb, cruise, descent, landing) to pilots in response to situations wherein the measured air data should not be relied upon. This information is presented in an intuitive and expedient manner exactly when and where it is needed on the primary flight display. The displayed information dynamically changes in response to airplane parameters.
Patent AU-2012261537-A1 (AU)
Title: Patient information management system
IPC: A61B5/00
Filed: 2012-11-30
Abstract: A computer-implemented system (10) for patient information management, including at least one database (20) having a plurality of data fields populated with patient data, clinician data, physician data, healthcare provider data, device data, medical data, health data, presentation data, identification data, administrator data, or any combination thereof. The system provides a patient information interface (12) in communication with the at least one database for selectively and dynamically presenting data fields to the users that are configured for access to the interface. A set of program instructions is configured to facilitate communication of data between at least one patient device and the system. A communication for patient information management and a method of facilitating the secure transmission of data of a patient device over a network to a patient management system are also disclosed. WO 2008/057951 PCT/US2007/083357 Data Am r0\ Cq N Qr I-n
Patent AU-2012265590-A1 (AU)
Title: Electric Generator
Inventor: BERGENER II ROBERT H
IPC: H01M4/00
Filed: 2012-12-19
Abstract: [0139] Methods, compositions, and apparatus for generating electricity are provided. Electricity is generated through the mechanisms nuclear magnetic spin and remnant polarization electric generation. The apparatus may include a material with high nuclear magnetic spin or high remnant polarization coupled with a poled ferroelectric material. The apparatus may also include a pair of electrical contacts disposed on opposite sides of the poled ferroelectric material and the high nuclear magnetic spin or high remnant polarization material. Further, a magnetic field may be applied to the high nuclear magnetic spin material. -48- Inventors: Robert H. Burgener, 11 and Gary M. Renlund Docket No.: 1025.2.1 Electrical Contact Ferro Electric Volts Out High Nuclear Magnetic Spin Magnetic Field Fig. 5
Patent AU-2012286699-A1 (AU)
Title: Treatment of multiple sclerosis with combination of laquinimod and glatiramer acetate
Inventor: GILGUN YOSSI
IPC: A61K31/47
Filed: 2012-07-27
Abstract: This invention provides a method of treating a patient afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the patient laquinimod as an add-on therapy to or in combination with glatiramer acetate. This invention also provides a package and a pharmaceutical composition comprising laquinimod and glatiramer acetate for treating a patient afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides laquinimod for use as an add-on therapy or in combination with glatiramer acetate in treating a patient afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention further provides use of laquinimod and glatiramer acetate in the preparation of a combination for treating a patient afflicted with multiple sclerosis or presenting a clinically isolated syndrome.
Patent AU-2012292689-A1 (AU)
Title: Data transmission method and device for uplink short-latency communication
Inventor: ZHU SONG
IPC: H04L1/16
Filed: 2012-08-13
Abstract: The present invention provides a method and apparatus for data transmission of uplink short latency communications. The method comprises: a user equipment detects if the data needed to be transmitted is the data of short latency communications, if yes, according to the transmission format obtained previously, transmits the data of short latency communications to the base station on the dedicated transmission resource of short latency, wherein the dedicated transmission resource of short latency is used for transmitting the data of short latency communications.
Patent AU-2012298598-A1 (AU)
Title: Polypeptides having protease activity
Inventor: SJOEHOLM CARSTEN
IPC: C12N9/52
Filed: 2012-08-17
Abstract: The present invention relates to isolated polypeptides having protease activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptidesin e.g. animal feed and detergents.
Patent AU-2012310113-A1 (AU)
Title: Capsule for preparing a beverage
Inventor: RONDELLI RAFFAELE
IPC: B65D85/804
Filed: 2012-09-14
Abstract: The capsule (1) comprises a cup- shaped body (2) closed on the upper side by a lid (3). The main feature of the present invention consists in the fact that the capsule (1) presents in its inside a plurality of infusion chambers (7 and 8) each provided with a respective area for the inlet of a water flow and each provided with a respective area for the outlet of the infusion.
Patent AU-2012311908-A1 (AU)
Title: Yersinia outer protein m (YopM) in the treatment of psoriasis
Inventor: RUETER CHRISTIAN
IPC: A61P17/06
Filed: 2012-02-24
Abstract: The present invention relates to the use of Yersinia outer protein M (YopM)in the prevention and/or treatment of psoriasis by cutaneous, intradermalor subcutaneous administration. In particular,the present invention relates to the use of YopM in the treatment of plaque psoriasis, guttate psoriasis, inverse psoriasis, pustular psoriasis, erythrodermic psoriasis, arthritis psoriasis.
Patent AU-2012325732-A1 (AU)
Title: Signal tube connector
Inventor: BEZUIDENHOUT HENDRIK CORNELIUS
IPC: F42D1/04
Filed: 2012-10-11
Abstract: A signal tube connector which can be used with a number of signal tubes which includes a detonator receiving body and a retention member, wherein a signal tube locating space is formed between opposing surfaces of the body and the member and wherein the retention member is movable relative to the body and can be locked in place with a locking mechanism to retain signal tubes within the space.
Patent AU-2012334818-A1 (AU)
Title: Vibration analysis for blasting
Inventor: HENLEY KIM NIGEL
IPC: G01H1/00
Filed: 2012-11-09
Abstract: A process for vibration analysis, including the steps of: receiving synchronized motion measurements of particle motion in two or three orthogonal dimensions over a selected period of time at a plurality of different measurement locations; and determining one or more strain waveforms in the orthogonal dimensions in regions spanning the plurality of measurement locations using the motion measurements.
Patent AU-2012335080-A1 (AU)
Title: Compounds for the modulation of beta-catenin expression and uses thereof
Inventor: DUMBLE MELISSA
IPC: C07H21/04
Filed: 2012-11-09
Abstract: The invention relates to oligomer compounds (oligomers), which target beta-catenin mRNA in a cell, leading to reduced expression of beta-catenin. Reduction of beta-catenin expression is beneficial for a range of medical disorders, such as hyperproliferative disorders, such as cancers. The invention provides therapeutic compositions comprising oligomers and methods for modulating the expression of beta-catenin using said oligomers, including methods of treatment for hyperproliferative disorders including cancers such as multiple myeloma.
Patent AU-2012345609-A1 (AU)
Title: Insertable endoscopic instrument for tissue removal
Inventor: FURLONG COSME
IPC: A61B1/31
Filed: 2012-12-03
Abstract: An improved endoscopic instrument easily and efficiently obtains samples of multiple polyps from a patient by debriding one or more polyps and retrieving the debrided polyps without having to alternate between using a separate cutting tool and a separate sample retrieving tool and may be used with an endoscope.
Patent AU-2012348604-A1 (AU)
Title: Device for dosing an additive solution
Inventor: BAKKENES HENDRIKUS WILHELMUS
IPC: A23P1/06
Filed: 2012-12-03
Abstract: Device (1) and method for dosing an aqueous solution (2) of an additive, e.g., a non-caking agent, into an amount of a particulate material, such as a salt. The device comprises a conveyor (4) for transporting the particulate material and a dispenser (5) arranged above the conveyor. The dispenser is connected to a supply for the aqueous solution. The dispenser comprises a pouring outlet (10) extending over at least a part of the width of the conveyor (4). The additive solution is poured with a controlled flow velocity over at least a part of the width of the conveyor (4) transporting the particulate material.
Patent AU-2012351685-A1 (AU)
Title: FGFR antibody drug conjugates (ADCs) and the use thereof
Inventor: LERCHEN HANS-GEORG
IPC: A61K47/48
Filed: 2012-12-12
Abstract: The present application relates to new antibody drug conjugates (ADCs) of N,N dialkylauristatins directed against the target FGFR2, drug metabolites of said ADCs, a method for producing said ADCs, the use of said ADCs for the treatment and/or prevention of illnesses as well as the use of said ADCs for producing pharmaceuticals for the treatment and/or prevention of illnesses, particularly of hyperproliferative and/or angiogenic diseases such as carcinosis. Such treatments can be carried out as monotherapy or in combination with other pharmaceuticals or additional therapeutic measures.
Patent WO-2013152396-A1 (WO)
Title: Raccord pivotant
Inventor: PANNEKOEK ROBERT JOHN
IPC: F16L27/04
Filed: 2013-04-12
Abstract: L'invention porte sur un raccord pivotant, lequel raccord est principalement destiné à l'utilisation dans des poteaux d'éclairage. Le raccord pivotant comprend deux faces de portée annulaires orientées à 45° par rapport à un axe longitudinal du raccord, et un boulon central traversant les faces de portée de façon à maintenir le raccord en position.
Patent AU-2013200417-A1 (AU)
Title: A method of gaming, a game controller and a gaming system
Inventor: BOND ROWAN ARTHUR NEWMAN
IPC: A63F13/10
Filed: 2013-01-25
Abstract: A method of gaming in a gaming system comprising conducting a plurality of game rounds, determining as part 5 of each game round whether a designated game event has occurred, each designated game event conferring a benefit on the player in at least one game round, increasing a count in response to the designated game event occurring in a game round, and ending the series of game rounds in 10 response to the count reaching a designated number, whereby the number of game rounds is determined by occurrence of the designated game event in plural game rounds to thereby set a minimum number of game rounds. 4029568_1 (GHMaters) P79730.AU.2 rN m41 X CD C (D Ua) C) a) mu > wD 0) w (D 0 u (D a) > z (D o of 0) E .nE o E 0 U) o 0 Co C14 < (D CD , o 2) 0 c 0 cC o0 4) 0 a) 2 2 wD co 0) aL (D 0) a M >D
Patent AU-2013200935-A1 (AU)
Title: Spirit levels
Inventor: MARSHALL BRYAN HUGH
IPC: G01C9/24
Filed: 2013-02-20
Abstract: C:\RPoib\DCC\EJL\4 50897-..DOC- 8/0m2) 3 -6 A bubble vial for a spirit level, the vial having an upper wall which is curved from end-to end with a curvature which is greater within a central zone of the vial than in zones at 5 either side of the central zone, the curvature preferably being of elliptical form. The greater curvature within the central zone within which the bubble will lie in a level condition provides greater sensitivity of the vial as a level condition is approached.
Patent AU-2013203984-A1 (AU)
Title: Novel herbicides
Inventor: MATHEWS CHRISTOPHER JOHN
IPC: A01N43/16
Filed: 2013-04-11
Abstract: H:\skinernoen NRPrtbl\DCC\RXS\5067349_l.doc-I L04 20] Abstract Compounds of formula (1), wherein the substituents are as defined in claim 1, are suitable for use as herbicides. G, R R2 R 7 O,A y R 0
Patent AU-2013204429-A1 (AU)
Title: Compositions and methods for treatment of celiac disease
Inventor: ANDERSON ROBERT PAUL
IPC: C07K7/00
Filed: 2013-04-12
Abstract: The invention provides agents and vaccines for treating and diagnosing celiac disease. In particular, the present invention provides a combination of three peptides that are useful for treating and diagnosing celiac disease in a large proportion of patients.
Patent AU-2013205180-A1 (AU)
Title: Use of opioid antagonists to attenuate endothelial cell proliferation and migration
Inventor: MOSS JONATHAN
IPC: A61K31/451
Filed: 2013-04-14
Abstract: The invention provides methods of attenuating, eg. inhibiting or reducing, cellular proliferation and migration, particularly endothelial cell proliferation and migration, including that associated with angiogenesis, using opioid antagonists, including, but not limited to, those that are peripherally restricted antagonists. ME morphine r~~naloxone M= MNTX * MNTX + IuM morphine Concentlatlon (uM)
Patent AU-2013206423-A1 (AU)
Title: Fire booster cabinet & method
Inventor: GARDNER LYLE
IPC: A62C35/20
Filed: 2013-06-19
Abstract: A cabinet (1, 21, 31) for enclosing fire booster pipework is disclosed. The cabinet has a rectangular base (2) and a top (4) and a multiplicity of rectangular wall panels (6) each of the same width and height. The panel width is an integral fraction of the base length and the base length is an integral multiple of the base width. At least one of the panels (6) is provided with handles (7) and constitutes an access hatch. The panels (6) are preferably joined by adhesive tape (13) extending across abutting vertical edges of the panels. 5362C-AU a * 0 t rw. It a
Patent AU-2013218204-A1 (AU)
Title: Aqueous dispersion
Inventor: MORARU BOGDAN
IPC: C04B24/26
Filed: 2013-01-30
Abstract: The invention relates to a cement-free, aqueous polymer dispersion containing calcium silicate hydrate.
Patent AU-2013227994-A1 (AU)
Title: Compositions of PD-1 antagonists and methods of use
Inventor: LANGERMAN SOLOMON
IPC: A61K39/39
Filed: 2013-09-10
Abstract: H:\fm\Intrwovn\NRPortbl\DCC\FMT\5446060_I.doc-5/09/2013 Methods of treating cancer and infectious diseases utilizing a treatment regimen comprising administering a compound that reduces inhibitory signal transduction in T cells, in combination with a potentiating agent, such as cyclophosphamide, to product potent T cell mediated responses, as described. Compositions comprising the PD-1 antagonists and potentiating agents useful in the methods of the invention are also disclosed.